Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.57 |
| ▸ | IDO1 | P14902 | 2/20 | 0.49 |
| ▸ | AGXT | P21549 | 2/20 | 0.49 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 3/20 | 0.47 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9700877 | 0.84 | TAAR1 (0.39) | TAAR1 | |
| SCHEMBL9701935 | 0.81 | TAAR1 (0.52) | TAAR1IDO1AGXTCTBP2MAOB | |
| SCHEMBL9701625 | 0.78 | DRD2 (0.55) | TAAR1CTBP2 | |
| SCHEMBL9701676 | 0.77 | KDM4E (0.56) | TAAR1AOC3 | |
| SCHEMBL23014561 | 0.76 | CTBP2 (0.57) | TAAR1IDO1AGXTCTBP2MAOB | |
| SCHEMBL12107934 | 0.75 | TAAR1 (0.56) | TAAR1IDO1AGXTCTBP2MAOB | |
| SCHEMBL9701904 | 0.75 | ADRA1A (0.58) | TAAR1IDO1AOC3 | |
| SCHEMBL9702802 | 0.75 | ADRA1A (0.50) | TAAR1 | |
| SCHEMBL11109005 | 0.74 | TAAR1 (0.54) | TAAR1IDO1AGXTCTBP2MAOB | |
| SCHEMBL13958347 | 0.74 | CTBP2 (0.54) | TAAR1IDO1AGXTCTBP2MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5120764-A | Administering penicillamine and allenylamines to inhibit crosslinking of collagen | MERRELL DOW PHARMACEUTICALS INC. (US) | 1992-06-09 | — | — | US | disclosed |
| EP-0374440-A2 | Inhibitors of lysyl oxidase | MERRELL DOW PHARMACEUTICALS INC. (US) | 1990-06-27 | — | — | EP | disclosed |